DS
WVE icon

David Shaw’s Wave Life Sciences WVE Stock Holding History

David Shaw’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.3M Buy
1,772,228
+1,699,923
+2,351% +$11.3M ﹤0.01% 1785
2026
Q1 		$524K Sell
72,305
-193,827
-73% -$2.53M ﹤0.01% 3831
2025
Q4 		$4.52M Buy
+266,132
New +$2.7M ﹤0.01% 2389
2025
Q3 		– Sell
-271,474
Closed -$1.76M – 4974
2025
Q2 		$1.76M Buy
271,474
+164,920
+155% +$1.09M ﹤0.01% 2832
2025
Q1 		$861K Sell
106,554
-609,699
-85% -$6.67M ﹤0.01% 3180
2024
Q4 		$8.86M Buy
716,253
+297,792
+71% +$3.97M 0.01% 1582
2024
Q3 		$3.43M Buy
418,461
+309,894
+285% +$1.85M ﹤0.01% 2261
2024
Q2 		$542K Sell
108,567
-176,525
-62% -$1.01M ﹤0.01% 3577
2024
Q1 		$1.76M Buy
+285,092
New +$1.43M ﹤0.01% 2731
2022
Q4 		– Sell
-307,175
Closed -$1.11M – 5163
2022
Q3 		$1.11M Sell
307,175
-633,290
-67% -$2.1M ﹤0.01% 3518
2022
Q2 		$3.06M Sell
940,465
-150,835
-14% -$290K ﹤0.01% 2692
2022
Q1 		$2.18M Sell
1,091,300
-18,989
-2% -$46.5K ﹤0.01% 3203
2021
Q4 		$3.49M Buy
1,110,289
+8,639
+0.8% +$35.9K ﹤0.01% 2789
2021
Q3 		$5.4M Sell
1,101,650
-153,910
-12% -$933K ﹤0.01% 2045
2021
Q2 		$8.36M Sell
1,255,560
-6,549
-0.5% -$42.8K 0.01% 1647
2021
Q1 		$7.08M Sell
1,262,109
-237,150
-16% -$2.28M 0.01% 1606
2020
Q4 		$11.8M Buy
1,499,259
+792,844
+112% +$6.65M 0.01% 1286
2020
Q3 		$6M Buy
706,415
+144,454
+26% +$1.58M 0.01% 1570
2020
Q2 		$5.85M Buy
561,961
+529,849
+1,650% +$4.99M 0.01% 1554
2020
Q1 		$301K Buy
32,112
+9,564
+42% +$81.5K ﹤0.01% 3466
2019
Q4 		$181K Buy
22,548
+3,858
+21% +$94.6K ﹤0.01% 3821
2019
Q3 		$384K Sell
18,690
-67,289
-78% -$1.54M ﹤0.01% 3330
2019
Q2 		$2.24M Sell
85,979
-156,665
-65% -$4.39M ﹤0.01% 2163
2019
Q1 		$9.43M Buy
242,644
+117,353
+94% +$4.76M 0.01% 1146
2018
Q4 		$5.27M Buy
125,291
+16,177
+15% +$719K 0.01% 1488
2018
Q3 		$5.46M Buy
109,114
+31,142
+40% +$1.41M 0.01% 1530
2018
Q2 		$2.98M Buy
77,972
+20,920
+37% +$901K ﹤0.01% 1924
2018
Q1 		$2.29M Buy
57,052
+50,610
+786% +$2.13M ﹤0.01% 1960
2017
Q4 		$226K Buy
+6,442
New +$188K ﹤0.01% 3377

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GP
GSK plc London $602M AUM
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RAM
Readystate Asset Management Chicago, Illinois $2.93B AUM 18.57% 1-Year Est. Return

David Shaw's WVE Position: Q2 2026 in Review

David Shaw increased its Wave Life Sciences (WVE) stake by 2,351% in Q2 2026, buying an estimated $11.3M and bringing the position to 1,772,228 shares worth $10.3M. The position accounts for ﹤0.01% of the portfolio, ranked #1785.

David Shaw first reported a position in WVE in Q4 2017 and has held it in 29 quarters since. The position peaked at $11.8M in Q4 2020. 238 funds tracked by Wall St. Rank hold WVE as of Q2 2026.

  • David Shaw held 1,772,228 shares of Wave Life Sciences worth $10.3M as of Q2 2026.
  • David Shaw bought 1,699,923 Wave Life Sciences shares in Q2 2026, an estimated $11.3M.
  • Wave Life Sciences made up ﹤0.01% of David Shaw's portfolio in Q2 2026, its #1785 holding.
  • David Shaw first reported a position in Wave Life Sciences in Q4 2017 and has held it in 29 quarters since.
  • David Shaw's Wave Life Sciences position peaked at $11.8M in Q4 2020.
  • 238 funds tracked by Wall St. Rank held Wave Life Sciences as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.